RibiDSR is a high-performance gastrointestinal medication from MK Healthcare, specifically formulated to provide comprehensive relief from acid-related disorders. Combining the potent proton pump inhibitor (PPI) Rabeprazole (20mg) with the prokinetic agent Domperidone (30mg SR), these capsules offer a dual-action approach to digestive health. It is designed to suppress excessive gastric acid production while simultaneously improving gut motility, making it a go-to solution for individuals suffering from chronic discomfort.
The primary therapeutic benefit of RibiDSR lies in its effectiveness against Gastroesophageal Reflux Disease (GERD) and Peptic Ulcers. While Rabeprazole works to heal the stomach lining and esophagus by reducing acid levels, the Sustained Release (SR) Domperidone ensures that symptoms like bloating, fullness, and nausea are managed throughout the day. This combination is particularly beneficial for patients who experience "silent reflux" or those whose acidity is accompanied by a heavy feeling in the stomach after meals.
Manufactured under the Prevent Formulation division, RibiDSR is produced using advanced pharmaceutical technology to ensure maximum bioavailability and stable drug release. The DSR (Daily Sustained Release) technology allows for a steady therapeutic effect, often requiring only a single daily dose to maintain a symptom-free state. This convenience significantly improves patient compliance, ensuring that the recovery process for gastric erosions or hypersecretory conditions is consistent and effective.
For pharmaceutical distributors and healthcare providers, RibiDSR represents a vital asset in the antacid and anti-emetic market segment. Packaged in premium Alu-Alu strips to protect the integrity of the salts against moisture and heat, it meets the highest standards of the pharmaceutical industry. Whether for clinical prescription or as part of a PCD Pharma Franchise portfolio, RibiDSR stands as a trusted name for rapid, long-lasting relief from heartburn, acid reflux, and associated gastric distress.
What is RibiDSR Capsule primarily used for?
RibiDSR is a dual-action gastrointestinal medication used to treat acid-related disorders like GERD (Gastroesophageal Reflux Disease), peptic ulcers, and heartburn. It also effectively manages symptoms like bloating, nausea, and fullness after meals.
What is the composition of RibiDSR?
Each capsule contains a combination of Rabeprazole Sodium (20mg) in an enteric-coated form and Domperidone (30mg) in a Sustained Release (SR) formulation.
How does Rabeprazole work in RibiDSR?
Rabeprazole is a Proton Pump Inhibitor (PPI) that reduces the amount of acid produced in the stomach. This helps heal the stomach lining and esophagus while preventing acid reflux and burning sensations.
What is the role of Domperidone SR in this medication?
Domperidone is a prokinetic agent that improves gut motility by helping food move more quickly through the stomach and intestines. The Sustained Release (SR) version ensures that symptoms like nausea and bloating are controlled throughout the day.
Is RibiDSR effective for 'silent reflux'?
Yes, it is particularly beneficial for patients who experience silent reflux or heavy stomach feelings after eating, as it addresses both the chemical (acid) and mechanical (movement) aspects of digestion.
What does the 'DSR' in the name stand for?
DSR stands for Daily Sustained Release. This technology allows the medication to release its active ingredients steadily over time, often requiring only a single daily dose for effective symptom management.
Are there any side effects to watch out for?
Common side effects may include dry mouth, headache, or mild diarrhea. If you experience unusual symptoms like rapid heartbeat or severe dizziness, consult your healthcare provider immediately.
How is the quality of RibiDSR ensured?
RibiDSR is manufactured under the Prevent Formulation division in ISO-GMP certified facilities. It is packaged in premium Alu-Alu (10x10) strips to protect the medication from moisture and heat, ensuring full therapeutic potency.